Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
ABBOTT LABORATORIES

2. Address

Address1
1399 NEW YORK AVENUE, NW, #200
 Address2
​
City
WASHINGTON
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​Abbott Park
 State
​IL
 Zip Code
​60064
 Country
​USA
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​PETER KELLY
​2023782025
​peter.kelly@abbott.com
5. Senate ID#
​66-12
7. Client Name Self Check if client is a state or local government or instrumentality
​ABBOTT LABORATORIES
6. House ID#
​300010000
TYPE OF REPORT 8. Year
​2008
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
 11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​880,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Peter E. Kelly - Director, Government Affairs Operations
 Date
04/21/2008

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

H.R. 3161, The Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008,
Title IV, WIC
Implementation issues for WIC reauthorization (legislative and regulatory)
H.R. 2419 Farm, Nutrition, and Bioenergy Act of 2007

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Cynthia B.
Sensibaugh
​
​
Howard D.
Scholick
​
​
Rosemary T.
Haas
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R.3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008, amendment 3327 and Title II relating to chronic kidney disease awareness, funding for state AIDS drugs assistance programs, under the Ryan White Care Act.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Rosemary T.
Haas
​
​
Jennifer M.
Luray
​
​
Jason
Grove
​
​
Sara
Garland
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

H.R.1908/S.1145 - Patent Reform Act of 2007

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Rosemary T.
Haas
​
​
Jason
Grove
​
​
Jennifer M.
Luray
​
​
Adele R.
Witenstein
​
​
Sara
Garland
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 3162, Childrens Health and Medicare Protection Act, Section 637
S. 2029 Physician Payments Sunshine Act of 2007
Implementation of H.R.3580, Food and Drug Administration Amendments Act of 2007

S.2731/H.R. 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008

S.1695, Biologics Price Competition and Innovation Act of 2007

S.623/H.R. 1038 Access to Life-Saving Medicine Act

H.R.5629 Pathway for Biosimilars Act

H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007


17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Cynthia B.
Sensibaugh
​
​
Jennifer M.
Luray
​
​
Adele R.
Witenstein
​
​
Howard D.
Scholick
​
​
Jason
Grove
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

S. 2221 - Transparency in Medical Device Pricing Act of 2007
H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007
Implementation of Section 641 of public law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003
HR 1321/S. 2404, Medicare Advanced Laboratory Diagnostics Act of 2007

Implementation of Section 302 of Public Law 108-173, Medicare Prescription Drug Improvement and Modernization Act of 2003

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Rosemary T.
Haas
​
​
Jason
Grove
​
​
Jennifer M.
Luray
​
​
Adele R.
Witenstein
​
​
Cynthia B.
Sensibaugh
​
​
Howard
Scholick
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

H.R. 2138 Investment in America Act
S. 2209 Research Credit Improvement Act of 2007
H.R. 5140 Economic Stimulus Act of 2008

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
Rosemary T.
Haas
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Intellectual Property Protection
World Health Organization Initiatives Related to Intellectual Property

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elaine R.
Leavenworth
​
​
P. Claude
Burcky
​
​
Andrea
Durkin
​
​
Rosemary T.
Haas
​
​
Howard D.
Scholick
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

H.R. 2272, America Competes Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Jennifer M.
Luray
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
 State
​
 Zip Code
​
 Country
​

21. Client new principal place of business (if different than line 20)

City
​
 State
​
 Zip Code
​
 Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6